USE OF MASITINIB FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160263110A1
SERIAL NO

15033797

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A treatment of patients afflicted with Amyotrophic Lateral Sclerosis (ALS), wherein the patients are treated with a tyrosine kinase inhibitor, mast cell inhibitor or c-Kit inhibitor, in particular masitinib, optionally in combination with at least one pharmaceutically active ingredient

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AB SCIENCEPARIS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
KINET, Jean Pierre Lexington, US 9 35
MANSFIELD, Colin Ecully, FR 13 37
MOUSSY, Alain Paris, FR 75 376

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation